Cubist Systematic Strategies LLC Has $417,000 Stock Position in Definitive Healthcare Corp. $DH

Key Points

• Cubist Systematic Strategies LLC significantly increased its holdings in Definitive Healthcare Corp. by 2,456.4%, acquiring an additional 138,640 shares during the 1st quarter, bringing its total to 144,284 shares.
• Definitive Healthcare has received mixed analyst opinions with an average rating of "Hold" and a consensus price target of $4.73, while Stifel Nicolaus has increased their target from $5.00 to $6.00.
• As of the latest report, Definitive Healthcare's stock is down 3.9%, opening at $3.98 with a market cap of $569.70 million and a 52-week range of $2.15 to $5.68.

Cubist Systematic Strategies LLC grew its position in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 2,456.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 144,284 shares of the company's stock after buying an additional 138,640 shares during the quarter. Cubist Systematic Strategies LLC owned approximately 0.13% of Definitive Healthcare worth $417,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Hsbc Holdings PLC acquired a new stake in shares of Definitive Healthcare during the 1st quarter valued at about $52,000. Cerity Partners LLC acquired a new stake in shares of Definitive Healthcare during the 1st quarter valued at about $56,000. ProShare Advisors LLC lifted its holdings in shares of Definitive Healthcare by 49.1% during the 4th quarter. ProShare Advisors LLC now owns 15,018 shares of the company's stock valued at $62,000 after buying an additional 4,943 shares during the last quarter. Meeder Asset Management Inc. acquired a new stake in Definitive Healthcare in the 1st quarter worth approximately $76,000. Finally, Price T Rowe Associates Inc. MD lifted its holdings in Definitive Healthcare by 20.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 20,572 shares of the company's stock worth $85,000 after purchasing an additional 3,496 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Definitive Healthcare Price Performance

NASDAQ DH traded up $0.02 during midday trading on Friday, hitting $4.15. The company had a trading volume of 322,528 shares, compared to its average volume of 248,421. The company has a market capitalization of $594.03 million, a PE ratio of -1.57 and a beta of 1.65. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.39. The firm has a 50-day moving average price of $3.97 and a 200-day moving average price of $3.41. Definitive Healthcare Corp. has a twelve month low of $2.15 and a twelve month high of $5.68.

Analyst Ratings Changes

Several research analysts have commented on the company. Stifel Nicolaus lifted their price target on Definitive Healthcare from $5.00 to $6.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. Wall Street Zen upgraded Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, June 21st. Finally, Robert W. Baird set a $4.00 price target on Definitive Healthcare in a research note on Friday, August 8th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $4.73.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.